Search Results - "Gabara, C."
-
1
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
Published in Infection (01-10-2022)“…Purpose Assess the impact of viral load estimated by cycle threshold (Ct) of reverse transcription real time-polymerase chain reaction (rRT-PCR) and the days…”
Get full text
Journal Article -
2
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
Published in Medicina intensiva (01-01-2023)“…To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. Retrospective observational and…”
Get full text
Journal Article -
3
PO-60: Comparison of inferior vena cava (IVC) filter use and outcomes between cancer and non-cancer patients in a single-center cohort
Published in Thrombosis research (01-05-2022)Get full text
Journal Article -
4
Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis
Published in Journal of thrombosis and haemostasis (01-08-2021)“…Introduction Some local protocols suggest using intermediate or therapeutic doses of anticoagulants for thromboprophylaxis in hospitalized patients with…”
Get full text
Journal Article -
5
TEMPORARY REMOVAL: PO-60: Comparison of inferior vena cava (IVC) filter use and outcomes between cancer and non-cancer patients in a single-center cohort
Published in Thrombosis research (01-05-2022)“…The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the…”
Get full text
Journal Article -
6
Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry
Published in Journal of the American Geriatrics Society (JAGS) (01-01-2024)“…Background Age is a major risk factor for venous thromboembolism (VTE), yet patients aged ≥90 years are under‐represented in clinical trials of anticoagulant…”
Get full text
Journal Article -
7
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
Published in Medicina intensiva (English ed.) (01-01-2023)“…To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. Retrospective observational and…”
Get full text
Journal Article -
8
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
Published in Medicina intensiva (English ed.) (30-07-2021)“…To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. Retrospective observational and…”
Get full text
Journal Article -
9
Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia
Published in Blood advances (24-09-2024)“…•In a RIETE registry analysis of 103 818 patients with VTE, 20.3% were tested for IT, showing a substantial variance in outcomes.•A thoughtful IT testing…”
Get full text
Journal Article -
10
HIGHaRESOLUTION (PIXE) ANALYSES OF CARBONATE DEPOSITS IN A ROMAN AQUEDUCT (FRAJUS, SE FRANCE): IMPLICATIONS FOR THE STUDY OF PALAEOHYDROLOGICAL VARIABILITY AND WATER RESOURCES MANAGEMENT IN SOUTHERN GAUL DURING THE ROMAN PERIOD
Published in Archaeometry (01-04-2011)“…Urban water was supplied to the Roman city of Forum Julii (Frejus, southeastern France) for at least 200 years by a 39.4km long aqueduct, operating in ad 50…”
Get full text
Journal Article -
11
Optimal thromboprophylaxis and anticoagulant strategies in patients with COVID-19 pneumonia. The PROTHROMCOVID Trial
Published in European heart journal (03-10-2022)“…Abstract Introduction Hospitalized patients with COVID-19 are at increased risk of venous and arterial thrombosis, ARDS, and death. The optimal dosage of…”
Get full text
Journal Article